Tech Company Financing Transactions
Verve Therapeutics Funding Round
GV, Arch Venture Partners and Biomatics Capital Partners joined a $63 million Series A funding round for Verve Therapeutics. The financing round was announced on 6/12/2020.
Transaction Overview
GV (Lead Investor) (Krishna Yeshwant)
Arch Venture Partners (John Evans)
Wellington Management Company (Robert Deresiewicz)
Company Information
Cambridge, MA 02139
USA
Management Team
Browse more venture capital transactions:
Prev: 6/12/2020: Wellsheet venture capital transaction
Next: 6/15/2020: Trade Hounds venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs